Enhancing the impact of antiretroviral scale-up on the HIV-associated tuberculosis epidemic in Malawi

被引:0
|
作者
Lawn, Stephen D. [1 ,2 ]
机构
[1] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England
[2] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Cape Town, South Africa
来源
PUBLIC HEALTH ACTION | 2014年 / 4卷 / 03期
基金
英国惠康基金;
关键词
D O I
10.5588/pha.14.0067
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:204 / 204
页数:1
相关论文
共 50 条
  • [1] GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
    Saeed, Muhammad
    Hussain, Shahida
    Riaz, Saba
    Rasheed, Farhan
    Ahmad, Maqsood
    Iram, Shagufta
    Arif, Mizna
    Rahmani, Tariq Hamid
    Anwar, Ambereen Imran
    [J]. OPEN LIFE SCIENCES, 2020, 15 (01): : 458 - 465
  • [2] HIV-associated mortality in the era of antiretroviral therapy scale-up - Nairobi, Kenya, 2015
    Young, Peter W.
    Kim, Andrea A.
    Wamicwe, Joyce
    Nyagah, Lilly
    Kiama, Catherine
    Stover, John
    Oduor, Johansen
    Rogena, Emily A.
    Walong, Edwin
    Zielinski-Gutierrez, Emily
    Imbwaga, Andrew
    Sirengo, Martin
    Kellogg, Timothy A.
    De Cock, Kevin M.
    [J]. PLOS ONE, 2017, 12 (08):
  • [3] The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi
    Tweya, Hannock
    Feldacker, Caryl
    Mpunga, James
    Kanyerere, Henry
    Heller, Tom
    Ganesh, Prakash
    Nkosi, Dave
    Kalulu, Mike
    Sinkala, George
    Satumba, Thomas
    Phiri, Sam
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (04)
  • [4] GeneXpert® assay; and its performance for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
    Rasheed, F.
    Saeed, M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 287 - 287
  • [5] Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi
    Kanyerere, H.
    Mganga, A.
    Harries, A. D.
    Tayler-Smith, K.
    Jahn, A.
    Chimbwandira, F. M.
    Mpunga, J.
    [J]. PUBLIC HEALTH ACTION, 2014, 4 (02): : 113 - 115
  • [6] Antiretroviral therapy for HIV-associated tuberculosis
    Avihingsanon, Anchalee
    Hemachandra, Atchariya
    van de Lugt, Jasper
    [J]. ASIAN BIOMEDICINE, 2009, 3 (01) : 73 - 87
  • [7] Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016
    Otieno, George
    Whiteside, Yohance Omar
    Achia, Thomas
    Kwaro, Daniel
    Zielinski-Gutierrez, Emily
    Ojoo, Sylvia
    Sewe, Maquins
    Musingila, Paul
    Akelo, Victor
    Obor, David
    Nyaguara, Amek
    De Cock, Kevin M.
    Borgdorff, Martien W.
    [J]. AIDS, 2019, 33 (15) : 2423 - 2430
  • [8] Antiretroviral Therapy for Control of the HIV-associated MDR and XDR Tuberculosis Epidemic in South Africa
    Lawn, Stephen D.
    Wood, Robin
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (12) : 1567 - 1567
  • [9] Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings
    Lawn, Stephen D.
    Kranzer, Katharina
    Wood, Robin
    [J]. CLINICS IN CHEST MEDICINE, 2009, 30 (04) : 685 - +
  • [10] When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis
    Toeroek, M. Estee
    Farrar, Jeremy J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1538 - 1540